HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

NCT/Study#

NCT05009992 /

PNOC-022

A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas (DMGs) including Diffuse Intrinsic Pontine Gliomas (DIPGs) at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression

DISEASE GROUP:
Pediatric Oncology
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information: